View Future GrowthEncres Dubuit 과거 순이익 실적과거 기준 점검 0/6Encres Dubuit 의 수입은 연평균 -63.8%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 7.4%의 비율로 증가했습니다. 매출은 연평균 1.2%의 비율로 감소해 왔습니다.핵심 정보-63.83%순이익 성장률-63.25%주당순이익(EPS) 성장률Chemicals 산업 성장률10.42%매출 성장률-1.24%자기자본이익률-29.77%순이익률-24.59%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updates공시 • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory FranceNew Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).New Risk • Dec 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Market cap is less than US$10m (€7.42m market cap, or US$8.65m). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change).분석 기사 • Sep 25Why Investors Shouldn't Be Surprised By Encres Dubuit's (EPA:ALDUB) Low P/SEncres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared...공시 • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory FranceNew Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.14m).분석 기사 • Mar 05Encres Dubuit (EPA:ALDUB) Surges 28% Yet Its Low P/S Is No Reason For ExcitementEncres Dubuit ( EPA:ALDUB ) shareholders would be excited to see that the share price has had a great month, posting a...분석 기사 • Nov 13Encres Dubuit's (EPA:ALDUB) Share Price Boosted 28% But Its Business Prospects Need A Lift TooDespite an already strong run, Encres Dubuit ( EPA:ALDUB ) shares have been powering on, with a gain of 28% in the last...분석 기사 • Sep 07Encres Dubuit's (EPA:ALDUB) Share Price Is Matching Sentiment Around Its RevenuesWith a price-to-sales (or "P/S") ratio of 0.4x Encres Dubuit ( EPA:ALDUB ) may be sending bullish signals at the...공시 • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory FranceReported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.New Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.72m). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (6.7% average weekly change).분석 기사 • Apr 16Some Confidence Is Lacking In Encres Dubuit's (EPA:ALDUB) P/SThere wouldn't be many who think Encres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.5x is worth a...New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.Upcoming Dividend • Jun 19Upcoming dividend of €0.30 per share at 7.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 28 June 2023. Trailing yield: 7.4%. Within top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €3.72, the stock trades at a forward P/E ratio of 76x. Average forward P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 26% over the past three years.분석 기사 • Oct 13Returns On Capital At Encres Dubuit (EPA:ALDUB) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.분석 기사 • Feb 07These Return Metrics Don't Make Encres Dubuit (EPA:ALDUB) Look Too StrongIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 18New 90-day high: €4.40The company is up 18% from its price of €3.72 on 19 November 2020. The French market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.Is New 90 Day High Low • Jan 19New 90-day high: €4.30The company is up 26% from its price of €3.42 on 21 October 2020. The French market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.Is New 90 Day High Low • Dec 18New 90-day high: €3.78The company is up 3.0% from its price of €3.66 on 18 September 2020. The French market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is down 3.0% over the same period.Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.Is New 90 Day High Low • Oct 12New 90-day low: €3.48The company is down 9.0% from its price of €3.82 on 14 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.Is New 90 Day High Low • Sep 18New 90-day low: €3.66The company is down 4.0% from its price of €3.80 on 19 June 2020. The French market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.매출 및 비용 세부 내역Encres Dubuit가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이ENXTPA:ALDUB 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 2518-48030 Sep 2518-38031 Dec 2420-18030 Sep 2420-18030 Jun 2420-28031 Mar 2420-28031 Dec 2320-28030 Sep 2321-28030 Jun 2322-18031 Mar 2322-18031 Dec 222308030 Sep 222208030 Jun 222118031 Mar 222118031 Dec 212117030 Sep 212017030 Jun 212007031 Mar 211907031 Dec 2019-17030 Sep 2019-17030 Jun 2020-17031 Mar 202207031 Dec 192407030 Sep 192418030 Jun 192518031 Mar 192518031 Dec 182517030 Sep 182417030 Jun 182317031 Mar 182317031 Dec 172217031 Dec 162117031 Mar 162127031 Dec 152127030 Sep 1521260양질의 수익: ALDUB 은(는) 현재 수익성이 없습니다.이익 마진 증가: ALDUB는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ALDUB은 수익성이 없으며 지난 5년 동안 손실이 연평균 63.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 ALDUB의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: ALDUB은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(6.4%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ALDUB는 현재 수익성이 없으므로 자본 수익률이 음수(-29.77%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 12:24종가2026/05/25 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Encres Dubuit는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Stephanie LefebvreGilbert DupontSandrine CauvinGilbert Dupont
Reported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.
Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.
Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
공시 • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory France
New Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).
New Risk • Dec 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Market cap is less than US$10m (€7.42m market cap, or US$8.65m). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change).
분석 기사 • Sep 25Why Investors Shouldn't Be Surprised By Encres Dubuit's (EPA:ALDUB) Low P/SEncres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared...
공시 • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory France
New Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.14m).
분석 기사 • Mar 05Encres Dubuit (EPA:ALDUB) Surges 28% Yet Its Low P/S Is No Reason For ExcitementEncres Dubuit ( EPA:ALDUB ) shareholders would be excited to see that the share price has had a great month, posting a...
분석 기사 • Nov 13Encres Dubuit's (EPA:ALDUB) Share Price Boosted 28% But Its Business Prospects Need A Lift TooDespite an already strong run, Encres Dubuit ( EPA:ALDUB ) shares have been powering on, with a gain of 28% in the last...
분석 기사 • Sep 07Encres Dubuit's (EPA:ALDUB) Share Price Is Matching Sentiment Around Its RevenuesWith a price-to-sales (or "P/S") ratio of 0.4x Encres Dubuit ( EPA:ALDUB ) may be sending bullish signals at the...
공시 • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory France
Reported Earnings • May 09Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in France.
New Risk • Apr 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.72m). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (6.7% average weekly change).
분석 기사 • Apr 16Some Confidence Is Lacking In Encres Dubuit's (EPA:ALDUB) P/SThere wouldn't be many who think Encres Dubuit's ( EPA:ALDUB ) price-to-sales (or "P/S") ratio of 0.5x is worth a...
New Risk • Feb 09New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).
Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.
Upcoming Dividend • Jun 19Upcoming dividend of €0.30 per share at 7.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 28 June 2023. Trailing yield: 7.4%. Within top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%).
Price Target Changed • Nov 08Price target decreased to €4.40Down from €4.80, the current price target is provided by 1 analyst. New target price is 24% above last closing price of €3.54. Stock is down 7.3% over the past year. The company is forecast to post earnings per share of €0.047 for next year compared to €0.30 last year.
Reported Earnings • Nov 03First half 2022 earnings released: EPS: €0.001 (vs €0.096 in 1H 2021)First half 2022 results: EPS: €0.001 (down from €0.096 in 1H 2021). Revenue: €11.1m (up 7.4% from 1H 2021). Net income: €4.0k (down 99% from 1H 2021). Profit margin: 0% (down from 2.8% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €3.72, the stock trades at a forward P/E ratio of 76x. Average forward P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 26% over the past three years.
분석 기사 • Oct 13Returns On Capital At Encres Dubuit (EPA:ALDUB) Paint A Concerning PictureDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Reported Earnings • Jul 05Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €20.7m (up 11% from FY 2020). Net income: €905.0k (up €1.46m from FY 2020). Profit margin: 4.4% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 3.7%, compared to a 25% growth forecast for the industry in France.
분석 기사 • Feb 07These Return Metrics Don't Make Encres Dubuit (EPA:ALDUB) Look Too StrongIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Reported Earnings • Oct 22First half 2021 earnings released: EPS €0.096 (vs €0.21 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €10.3m (up 19% from 1H 2020). Net income: €292.0k (up €950.0k from 1H 2020). Profit margin: 2.8% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 18New 90-day high: €4.40The company is up 18% from its price of €3.72 on 19 November 2020. The French market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Jan 19New 90-day high: €4.30The company is up 26% from its price of €3.42 on 21 October 2020. The French market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Dec 18New 90-day high: €3.78The company is up 3.0% from its price of €3.66 on 18 September 2020. The French market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is down 3.0% over the same period.
Price Target Changed • Nov 01Price target lowered to €3.70Down from €4.10, the current price target is provided by 1 analyst. The new target price is 9.5% above the current share price of €3.38. As of last close, the stock is down 14% over the past year.
Major Estimate Revision • Nov 01Analysts lower revenue estimates to €17.9mThe 2020 consensus revenue estimate decreased from €19.9m. Earnings per share (EPS) also decreased, with analysts lowering their estimates from -€0.41 to -€0.42 for the same period. The Chemicals industry in France is expected to see an average net income growth of 3.8% next year. The consensus price target was lowered from €4.10 to €3.70. Share price stayed mostly flat at €3.38 over the past week.
Is New 90 Day High Low • Oct 12New 90-day low: €3.48The company is down 9.0% from its price of €3.82 on 14 July 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.
Is New 90 Day High Low • Sep 18New 90-day low: €3.66The company is down 4.0% from its price of €3.80 on 19 June 2020. The French market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.